Therefore, the fibrinogen-to-albumin ratio (FAR) [26–32], which is composed of plasma fibrinogen and serum albumin, combines the patient's inflammation, coagulation and nutritional situation, and may be a valuable model to assess the poor outcomes of HCC patients. The gene discussed is ALB; the disease is hepatocellular carcinoma.